| [1] |
YI Shanye, YANG Rong, LIAO Xiaoyang, ZHOU Yiheng, LIU Lidi, YANG Ziyu, BAI Jiaxin, JIA Yu, ZHANG Xin.
Interpretation of the 2024 Blood Pressure Measurement and Assessment of Arterial Structure and Function: an Expert Group Position Paper
[J]. Chinese General Practice, 2026, 29(32): 4690-4694.
|
| [2] |
GUO Junchi, ZHANG Mingyan, QIN Guangning, XU Qiang, LU Meijuan.
Preliminary Application of the Novel Biomarker TANS01 in Cardiovascular Risk Assessment among Individuals with Phlegm-dampness Constitution
[J]. Chinese General Practice, 2026, 29(27): 3924-3930.
|
| [3] |
ZHAO Yuanyuan, LIU Pulin, DAI Juan, ZHANG Gang, ZHANG Wei, ZHANG Xiaoxia, DENG Qing, YAN Yaqiong.
Association Study between Chinese Visceral Adiposity Index and Risk of All-cause and Cause-specific Mortality in the Elderly
[J]. Chinese General Practice, 2026, 29(26): 3781-3787.
|
| [4] |
YANG Rui, LIAO Xiaoyang, HUANG Chuanying, YANG Ziyu, SHEN Can, JIA Yu, LIU Lidi, YANG Rong.
Interpretation of the 2024 British and Irish Hypertension Society Position Statement: Investigation and Management of Hypertension in Young People
[J]. Chinese General Practice, 2026, 29(26): 3726-3732.
|
| [5] |
YANG Xu, FAN Jieting, SONG Hongyan, FENG Panpan, HAO Jingyu, YAO Mi.
Risk Assessment and Communication Strategies for Cardiovascular Diseases in Primary Care
[J]. Chinese General Practice, 2026, 29(10): 1294-1299.
|
| [6] |
PEI Zhiyi, ZHANG Xiaoxin, LIN Jiayi, ZHANG Xiangyi, KANG Xiaofeng.
Systematic Review of the Quality and Application of Patient Decision Aids in Cardiovascular Disease Based on IPDAS 4.0 Criteria
[J]. Chinese General Practice, 2026, 29(07): 945-952.
|
| [7] |
BAI Ruirui, LU Xiaoqin, DU Fengdong.
Knowledge, Attitudes, and Practice Toward Polypharmacy and Potentially Inappropriate Medication among General Practitioners: a Cross-sectional Study
[J]. Chinese General Practice, 2026, 29(07): 907-913.
|
| [8] |
FAN Zhuanzhuan, LI Wenting, MA Guoliang.
Relationship between the Chinese Visceral Adipose Index and Cardiovascular Disease in Postmenopausal Women: a Prospective Cohort Study
[J]. Chinese General Practice, 2026, 29(02): 180-187.
|
| [9] |
ZHANG Shu, CHENG Yu, WU Shouling, CHEN Shuohua, WU Yuntao.
The Impact of Cumulative Plasma Atherogenic Index Exposure on Incident Cardiovascular Disease in Non-Diabetic Individuals: a Cohort Study
[J]. Chinese General Practice, 2025, 28(36): 4558-4565.
|
| [10] |
SUN Jiaying, ZHOU Pengxiang, XIA Yu, YAN Ming, ZHOU Xinmei, WU Lingyan, TONG Yuling, ZHAO Yang, XU Zhijie.
Interpretation of a Position Statement from an Italian Scientific Consortium: Medication Review and Deprescribing
[J]. Chinese General Practice, 2025, 28(36): 4550-4557.
|
| [11] |
ZHANG Ying, LIAO Xiaoyang, YANG Hanfei, YU Yongjun, LIU Lidi, JIA Yu, SHEN Can, LI Xiao, HUANG Chuanying, YANG Rong.
Interpretation of the 2024 International Society of Hypertension Position Paper on Innovations in Blood Pressure Measurement and Reporting Technology and Its Implications for China
[J]. Chinese General Practice, 2025, 28(36): 4541-4549.
|
| [12] |
ZHAO Zhuo, WANG He.
Research Progress on the Mechanism of HIF-2α in Cardiovascular Diseases
[J]. Chinese General Practice, 2025, 28(33): 4241-4248.
|
| [13] |
LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu.
Interpretation of Report on Cardiovascular Health and Diseases in China 2024
[J]. Chinese General Practice, 2025, 28(32): 3989-4008.
|
| [14] |
ZHANG Hui, YANG Jianjun, HE Guoshu, XING Guoqiang, REN Jingjing.
The Cognitive Status of the Prescription of Chinese Patent Medicines and Training Needs of General Practitioners in China
[J]. Chinese General Practice, 2025, 28(31): 3954-3960.
|
| [15] |
ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping.
Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases
[J]. Chinese General Practice, 2025, 28(27): 3466-3472.
|